According to a study released by the American Journal of Obstetrics and Gynecology, the Moderna and Pfizer-BioNTech jabs, which are the two out of three COVID-19 jabs currently being used in the United States, have demonstrated signs of effectiveness in women who are pregnant and/or lactating, according to US media reports.

Moreover, the studies show that the antibodies, which develop due to the presence of the vaccine, are being passed on to the child, reported CNN. 

Also Read: Pfizer begins COVID vaccine trial for children under the age of 11

The testing pool, which was created by reputed US-based institutions, accounted for 31 lactating participants, 84 pregnant and 16 who were not pregnant. The participants in the study were inoculated with Moderna and Pfizer jabs.  

The study, which included a comparison between the antibodies produced by the COVID-19 vaccine and those generated in the body after recovering from the infection, found a difference that was “strikingly higher” in pregnant women. The levels of protective antibodies in pregnant and lactating women, after both variants of the vaccine, were found to be at par reported CNN.

Also Read: Blunders from AstraZeneca fuels vaccine scepticism in US

However, the Moderna vaccine took a leap ahead after it provided higher levels of the IgA antibody, which is known to have a rate of transmission to the offspring. 

The United States Centres for Disease Control and Prevention, which prepares to evaluate the safety and efficacy of the available COVID-19 jabs in the US for pregnant people has previously affirmed that testing positive for COVID-19 while being pregnant can result in complications in the pregnancy cycle.